APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 2 filers reported holding APTOSE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $424,324 | +9.7% | 663,007 | -0.5% | 0.00% | – |
| Q4 2022 | $386,632 | +97288.4% | 666,607 | 0.0% | 0.00% | – |
| Q3 2022 | $397 | -19.8% | 666,607 | 0.0% | 0.00% | – |
| Q2 2022 | $495 | -99.9% | 666,607 | 0.0% | 0.00% | – |
| Q1 2022 | $907,000 | +0.8% | 666,607 | 0.0% | 0.00% | – |
| Q4 2021 | $900,000 | -45.1% | 666,607 | -11.3% | 0.00% | – |
| Q3 2021 | $1,639,000 | -26.1% | 751,802 | +12.5% | 0.00% | – |
| Q2 2021 | $2,219,000 | -44.4% | 668,488 | +0.1% | 0.00% | -100.0% |
| Q1 2021 | $3,990,000 | +36.6% | 667,765 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $2,920,000 | -30.5% | 666,673 | -4.8% | 0.00% | 0.0% |
| Q3 2020 | $4,204,000 | -1.5% | 700,602 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $4,269,000 | +5.6% | 676,470 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $4,044,000 | +2427.5% | 680,767 | +2314.9% | 0.00% | – |
| Q4 2019 | $160,000 | – | 28,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 690,000 | $4,123,000 | 3.63% |
| DRW Securities, LLC | 7,976,176 | $47,658,000 | 1.89% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $8,420,000 | 1.61% |
| Nantahala Capital Management | 7,738,892 | $46,240,000 | 1.35% |
| PRECEPT MANAGEMENT LLC | 330,766 | $1,976,000 | 1.35% |
| First Light Asset Management, LLC | 3,102,788 | $18,539,000 | 1.23% |
| Voss Capital, LP | 440,000 | $2,629,000 | 1.10% |
| VR Adviser, LLC | 1,605,400 | $9,592,000 | 1.04% |
| Endurant Capital Management LP | 517,472 | $3,092,000 | 0.81% |
| Opaleye Management Inc. | 871,800 | $5,209,000 | 0.76% |